Screener
NewAmsterdam Pharma Company NAMS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's free cash flow?
- NewAmsterdam Pharma Company (NAMS) reported free cash flow of -$39.29M in Q2 2026.
- How has NewAmsterdam Pharma Company's free cash flow changed year-over-year?
- NewAmsterdam Pharma Company's free cash flow decreased by 4.1% year-over-year, from -$37.76M to -$39.29M.
- What is the long-term trend for NewAmsterdam Pharma Company's free cash flow?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's free cash flow has grown at a 49.6% compound annual growth rate (CAGR), from -$29.54M to -$148.03M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about NewAmsterdam Pharma Company's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude